Delivery Order SPE2DB24D1021-SPE2DB25FEXGH
- Not listed
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order worth $11,642.60 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the delivery of 200 unit BOTOX vials to a location in Conshohocken, Pennsylvania by March 19, 2024. This award is part of Amerisourcebergen Drug Corp's role as the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to...
- The Defense Logistics Agency awarded a delivery order valued at $7,227.00 to AmerisourceBergen Drug Corp for the supply of Botox 200 unit vials, with an ultimate completion date of August 25, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary operations. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,821.85 to AmerisourceBergen Drug Corp for the supply of BOTOX 200 unit vials. This firm fixed price contract was competitively awarded without set-aside designation and is scheduled for completion by August 18, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion comprehensive pharmaceutical supply vehicle...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,273.95 to AmerisourceBergen Drug Corp for the supply of Botox 200 unit vials, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order was issued under no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a...
- The Defense Logistics Agency awarded a $4,306.80 delivery order to AmerisourceBergen Drug Corp for the supply of Botox 100 unit vials, with an ultimate completion date of August 25, 2025. This is a firm fixed-price, non-set-aside contract with performance taking place in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026,...
- The Defense Logistics Agency awarded a delivery order valued at $4,306.80 to AmerisourceBergen Drug Corp for the supply of BOTOX 100 Unit Vials. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by August 6, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate office location in Conshohocken, PA. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,722.72 to AmerisourceBergen Drug Corp for BOTOX 100 Unit Vials, with an ultimate completion date of August 20, 2025. This non-set-aside, firm fixed price delivery order was competitively awarded and represents a child contract under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor will fulfill this order from its corporate office location in...
- The Defense Logistics Agency awarded a $3,419.20 firm fixed price delivery order to AmerisourceBergen Drug Corp for 200-unit vials of Botox, with a completion date of June 24, 2025. This is a non-set-aside competitive award executed as a child contract under AmerisourceBergen's broader pharmaceutical supply arrangements with DLA. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite...
- The Defense Logistics Agency awarded a $3,011.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 200-unit vials of Botox, with an ultimate completion date of August 19, 2025. The contract, which was competitively awarded with no set-aside designation, is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $3,574.80 on September 15, 2025, for the supply of BOTOX Cosmetic 100 Unit Vials, with an ultimate completion date of October 6, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania,...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEXGHDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,445.44 to AmerisourceBergen Drug Corp for the supply of Botox 100 unit vials. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order with an ultimate completion date of June 24, 2025. The contract is being performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle running through December 2026. The IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. Through this flexible contract vehicle, the company serves critical customers including the Defense Health Agency and other government healthcare systems, positioning it as a key vendor within DLA's pharmaceutical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 6/2/25 |